LGRRX
Price
$26.67
Change
+$0.01 (+0.04%)
Updated
Dec 20 closing price
RGEBX
Price
$72.22
Change
+$0.65 (+0.91%)
Updated
Dec 20 closing price
Ad is loading...

LGRRX vs RGEBX

Header iconLGRRX vs RGEBX Comparison
Open Charts LGRRX vs RGEBXBanner chart's image
Loomis Sayles Growth A
Price$26.67
Change+$0.01 (+0.04%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$72.22
Change+$0.65 (+0.91%)
VolumeN/A
CapitalizationN/A
LGRRX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGRRX vs. RGEBX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGRRX is a StrongBuy and RGEBX is a Buy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 301B vs. LGRRX (15.8B). RGEBX pays higher dividends than LGRRX: RGEBX (0.16) vs LGRRX (0.00). LGRRX was incepted earlier than RGEBX: LGRRX (28 years) vs RGEBX (10 years). RGEBX is a more actively managed with annual turnover of: 31.00 vs. LGRRX (13.00). RGEBX has a lower initial minimum investment than LGRRX: RGEBX (250) vs LGRRX (2500). LGRRX annual gain was more profitable for investors over the last year : 27.79 vs. RGEBX (19.08). LGRRX return over 5 years is better than : 55.96 vs. RGEBX (44.55).
LGRRXRGEBXLGRRX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years10 years-
Gain YTD27.60818.666148%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets15.8B301B5%
Annual Yield % from dividends0.000.16-
Returns for 1 year27.7919.08146%
Returns for 3 years5.962.62227%
Returns for 5 years55.9644.55126%
Returns for 10 years168.0769.24243%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PL4.040.16
+4.12%
Planet Labs PBC
FIVN42.631.15
+2.77%
Five9
VEEV224.154.48
+2.04%
Veeva Systems
PRQR2.630.04
+1.54%
ProQR Therapeutics NV
BIVI1.90-0.18
-8.65%
BioVie Inc